DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+12.87%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$478M
AUM Growth
+$478M
Cap. Flow
+$17.9M
Cap. Flow %
3.75%
Top 10 Hldgs %
53.49%
Holding
96
New
7
Increased
25
Reduced
16
Closed
12

Top Buys

1
TBPH icon
Theravance Biopharma
TBPH
$10M
2
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
$6.14M
3
OTIC
Otonomy, Inc.
OTIC
$4.44M
4
TBIO
Translate Bio, Inc. Common Stock
TBIO
$4.17M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
$2.93M

Top Sells

1
PLX icon
Protalix BioTherapeutics
PLX
$5.37M
2
ATRC icon
AtriCure
ATRC
$2.94M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$2.87M
4
ALEC icon
Alector
ALEC
$2.57M
5
AGTC
Applied Genetic Technologies Corporation
AGTC
$2.18M

Sector Composition

1 Healthcare 90.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STXS icon
1
Stereotaxis
STXS
$261M
$132M 27.58% 13,680,554 – –
FATE icon
2
Fate Therapeutics
FATE
$120M
$27.3M 5.71% 314,360 – –
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$19.1M 3.99% 510,756 -77,000 -13% -$2.87M
BPMC
4
DELISTED
Blueprint Medicines
BPMC
$18.3M 3.82% 207,911 – –
TBPH icon
5
Theravance Biopharma
TBPH
$699M
$10.6M 2.22% 732,345 +691,180 +1,679% +$10M
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$10.4M 2.18% 181,467 – –
TBIO
7
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$10.4M 2.17% 376,993 +151,600 +67% +$4.17M
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$9.68M 2.02% 170,306 -11,000 -6% -$625K
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.14M 1.91% 94,100 +500 +0.5% +$48.5K
DXCM icon
10
DexCom
DXCM
$29.5B
$9.03M 1.89% 21,138 – –
AFMD
11
DELISTED
Affimed
AFMD
$8.2M 1.72% 964,857 -25,000 -3% -$212K
ARNA
12
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8.16M 1.71% 119,615 +42,900 +56% +$2.93M
NRIX icon
13
Nurix Therapeutics
NRIX
$714M
$8.13M 1.7% 306,320 – –
XENE icon
14
Xenon Pharmaceuticals
XENE
$2.98B
$7.57M 1.58% 406,535 – –
ATRC icon
15
AtriCure
ATRC
$1.84B
$7.26M 1.52% 91,529 -37,000 -29% -$2.94M
NBIX icon
16
Neurocrine Biosciences
NBIX
$13.8B
$7.17M 1.5% 73,655 – –
IDYA icon
17
IDEAYA Biosciences
IDYA
$2.15B
$6.96M 1.46% 331,661 – –
PRQR icon
18
ProQR Therapeutics
PRQR
$237M
$6.96M 1.45% 1,031,880 -68,120 -6% -$459K
IBB icon
19
iShares Biotechnology ETF
IBB
$5.6B
$6.69M 1.4% 40,900 +500 +1% +$81.8K
RVMD icon
20
Revolution Medicines
RVMD
$7.1B
$6.66M 1.39% 209,731 +58,500 +39% +$1.86M
CSII
21
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.39M 1.34% 149,700 – –
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6.14M 1.28% +714,285 New +$6.14M
KRTX
23
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.04M 1.26% 53,000 +5,000 +10% +$570K
GLPG icon
24
Galapagos
GLPG
$2.07B
$5.35M 1.12% 77,675 +2,500 +3% +$172K
OTIC
25
DELISTED
Otonomy, Inc.
OTIC
$5.31M 1.11% 2,379,392 +1,989,800 +511% +$4.44M
1
2 3 4